Journal Scans
Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial
Benefit of Adjuvant PEFG in Operable Pancreatic Cancer
JM Reni, G Balzano, G Aprile, E Villa, et al
20120012
2012 Jan 12
Ann Surg Oncol
Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial
Ann Surg Oncol. 2012 Jan 12;[Epub Ahead of Print], JM Reni, G Balzano, G Aprile, E Villa, et al
TAKE-HOME MESSAGE
Abstract
Abstract
Background: Information from randomized trials on the role of combination chemotherapy in the adjuvant treatment of pancreatic adenocarcinoma is limited. This randomized phase II trial aimed to identify the most promising regimen warranting phase III evaluation.Methods: Therapy-naive patients, age 18-75 years, Karnofsky Performance Status (KPS) >60, gross total resection of stage IB-III pancreatic adenocarcinoma, stratified for center and surgical margins, were randomly assigned to receive either...